Paul W. Armstrong

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Paul W. Armstrong, Burkert Pieske, Kevin J. Anstrom et al. · New England Journal of Medicine · 2020 · 1.3K citations · Full text

Medicine, Cardiology, Pharmacology +11

N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes

Justin A. Ezekowitz, Christopher M. O’Connor, Richard W. Troughton et al. · JACC Heart Failure · 2020 · 139 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Aetiology, Timing and Clinical Predictors of Early vs. Late Readmission Following Index Hospitalization for Acute Heart Failure: Insights from ASCEND-HF

Marat Fudim, Christopher M. O’Connor, Allison Dunning et al. · European Journal of Heart Failure · 2017 · 61 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Differences in the Treatment of Myocardial Infarction Between the United States and Canada

Louise Pilote, C. B. Granger, Paul W. Armstrong et al. · Medical Care · 1995 · 57 citations

Medicine, Cardiology, Internal Medicine +13

Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND‐HF

Amanda Verma, Jie‐Lena Sun, Adrian F. Hernandez et al. · Clinical Cardiology · 2018 · 37 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14